Fourpath Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.63M Sell
35,307
-4,637
-12% -$1.08M 1.24% 18
2025
Q4
$8.27M Sell
39,944
-2,606
-6% -$515K 1.13% 27
2025
Q3
$7.89M Buy
42,550
+753
+2% +$129K 1.12% 27
2025
Q2
$6.38M Sell
41,797
-247
-0.6% -$38K 1% 26
2025
Q1
$6.97M Buy
42,044
+221
+0.5% +$34.6K 1.21% 20
2024
Q4
$6.05M Sell
41,823
-10,470
-20% -$1.62M 1.12% 24
2024
Q3
$8.47M Buy
52,293
+47,306
+949% +$7.54M 1.56% 13
2024
Q2
$729K Sell
4,987
-3
-0.1% -$446 0.54% 42
2024
Q1
$789K Buy
4,990
+29
+0.6% +$4.62K 0.55% 39
2023
Q4
$778K Sell
4,961
-11
-0.2% -$1.69K 0.53% 39
2023
Q3
$774K Sell
4,972
-89
-2% -$14.7K 0.58% 37
2023
Q2
$838K Sell
5,061
-15
-0.3% -$2.42K 1.01% 30
2023
Q1
$787K Sell
5,076
-7
-0.1% -$1.13K 0.55% 39
2022
Q4
$898K Sell
5,083
-3
-0.1% -$518 0.65% 37
2022
Q3
$831K Sell
5,086
-3
-0.1% -$508 0.57% 45
2022
Q2
$903K Sell
5,089
-161
-3% -$28.7K 0.56% 41
2022
Q1
$930K Sell
5,250
-53
-1% -$9.02K 0.37% 48
2021
Q4
$907K Buy
+5,303
New +$868K 0.35% 52

Other funds holding JNJ

Fourpath Capital Management's JNJ Position: Q1 2026 in Review

Fourpath Capital Management reduced its Johnson & Johnson (JNJ) stake by 12% in Q1 2026, selling an estimated $1.08M and leaving 35,307 shares worth $8.63M. The position accounts for 1.24% of the portfolio, ranked #18.

Fourpath Capital Management first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Fourpath Capital Management held 35,307 shares of Johnson & Johnson worth $8.63M as of Q1 2026.
  • Fourpath Capital Management sold 4,637 Johnson & Johnson shares in Q1 2026, an estimated $1.08M.
  • Johnson & Johnson made up 1.24% of Fourpath Capital Management's portfolio in Q1 2026, its #18 holding.
  • Fourpath Capital Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Fourpath Capital Management's 13F filing for Q1 2026, filed 1 May 2026.